Patients With Atopic Dermatitis Using Oral Contraceptive Pills or Hormone Replacement Therapy: Long-Term Safety of Upadacitinib for Major Adverse Cardiovascular Events, Venous Thromboembolism, or Malignancy (Excluding Nonmelanoma Skin Cancer). (2025). SKIN The Journal of Cutaneous Medicine, 9(6), s613. https://doi.org/10.25251/stfagt72